36 related articles for article (PubMed ID: 24132108)
1. CORR Insights®: Are IDH1 R132 Mutations Associated With Poor Prognosis in Patients With Chondrosarcoma of the Bone?
Ramsey DC
Clin Orthop Relat Res; 2024 Jun; 482(6):957-959. PubMed ID: 38446419
[No Abstract] [Full Text] [Related]
2. T cells take aim in AML: targeting IDH2.
Subklewe M
Blood; 2024 Apr; 143(17):1681-1682. PubMed ID: 38662383
[No Abstract] [Full Text] [Related]
3. Microenvironmental Metabolites in the Intestine: Messengers between Health and Disease.
Zaurito AE; Tschurtschenthaler M
Metabolites; 2022 Jan; 12(1):. PubMed ID: 35050167
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang.
Zhou HS; Carter BZ; Andreeff M
Cancer Biol Med; 2016 Jun; 13(2):248-59. PubMed ID: 27458532
[TBL] [Abstract][Full Text] [Related]
5. Isocitrate dehydrogenase 2 inhibits gastric cancer cell invasion via matrix metalloproteinase 7.
Wu D
Tumour Biol; 2016 Apr; 37(4):5225-30. PubMed ID: 26553362
[TBL] [Abstract][Full Text] [Related]
6. Sensitive Determination of Onco-metabolites of D- and L-2-hydroxyglutarate Enantiomers by Chiral Derivatization Combined with Liquid Chromatography/Mass Spectrometry Analysis.
Cheng QY; Xiong J; Huang W; Ma Q; Ci W; Feng YQ; Yuan BF
Sci Rep; 2015 Oct; 5():15217. PubMed ID: 26458332
[TBL] [Abstract][Full Text] [Related]
7. Potential mitochondrial isocitrate dehydrogenase R140Q mutant inhibitor from traditional Chinese medicine against cancers.
Lee WY; Chen KC; Chen HY; Chen CY
Biomed Res Int; 2014; 2014():364625. PubMed ID: 24995286
[TBL] [Abstract][Full Text] [Related]
8. High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma.
Liu WR; Tian MX; Jin L; Yang LX; Ding ZB; Shen YH; Peng YF; Zhou J; Qiu SJ; Dai Z; Fan J; Shi YH
J Exp Clin Cancer Res; 2014 Apr; 33(1):32. PubMed ID: 24716838
[TBL] [Abstract][Full Text] [Related]
9. Isocitrate dehydrogenase mutations in chondrosarcoma: the crossroads between cellular metabolism and oncogenesis.
Azzi G; Velez M; Mathias-Machado MC
Curr Opin Oncol; 2014 Jul; 26(4):403-7. PubMed ID: 24867810
[TBL] [Abstract][Full Text] [Related]
10. The biology and management of cartilaginous tumors: a role for targeting isocitrate dehydrogenase.
Tinoco G; Wilky BA; Paz-Mejia A; Rosenberg A; Trent JC
Am Soc Clin Oncol Educ Book; 2015; ():e648-55. PubMed ID: 25993236
[TBL] [Abstract][Full Text] [Related]
11. Metabolism: IDH2 drives cancer in vivo.
Lokody I
Nat Rev Cancer; 2013 Nov; 13(11):756-7. PubMed ID: 24132108
[No Abstract] [Full Text] [Related]
12. Anticancer drugs: IDH2 drives cancer in vivo.
Lokody I
Nat Rev Drug Discov; 2013 Nov; 12(11):826-7. PubMed ID: 24172328
[No Abstract] [Full Text] [Related]
13. Induction of sarcomas by mutant IDH2.
Lu C; Venneti S; Akalin A; Fang F; Ward PS; Dematteo RG; Intlekofer AM; Chen C; Ye J; Hameed M; Nafa K; Agaram NP; Cross JR; Khanin R; Mason CE; Healey JH; Lowe SW; Schwartz GK; Melnick A; Thompson CB
Genes Dev; 2013 Sep; 27(18):1986-98. PubMed ID: 24065766
[TBL] [Abstract][Full Text] [Related]
14. [I. Identification of a Possible Therapeutic Target for Chondrosarcoma with IDH Mutant Inhibitors].
Nakagawa M; Nakatani F; Kitabayashi I
Gan To Kagaku Ryoho; 2017 Mar; 44(3):212-216. PubMed ID: 28400543
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
